September 29, 2023
Training for a cellular battle against diabetes
The need for better options in diabetes care inspires Kyle Knofczynski, a student in the Regenerative Sciences Ph.D. track at the Mayo Clinic Graduate School of Biomedical Sciences. Standard insulin replacement therapy has been a lifeline for many people with diabetes, but it doesn’t always sufficiently control blood glucose (sugar). So Knofczynski dared to dream […]
Tags: #Diabetes, #diabetes research, #Dr. Quinn Peterson, #Kyle Knofczynski, #Mayo Clinic Graduate School of Biomedical Sciences, #Regenerative Sciences Ph.D. track, #Type 1 diabetes
May 7, 2020
A discovery step toward cell replacement therapy for diabetes
In what could be a step toward cell replacement therapy for diabetes, Mayo Clinic researchers have discovered how to manufacture cells capable of generating a hormone that regulates low blood sugar. Quinn Peterson, Ph.D. and his team have developed a new method of mass producing a cell product containing the hormone glucagon that is capable […]
Tags: #Biomanufacturing, #cell replacement therapy, #Diabetes, #Dr. Quinn Peterson, #hypoglycemia, #Mayo Clinic Center for Regenerative Medicine, #stem cells